PATIENT LEADER EDUCATION SUMMIT 2017
March 31 – April 1, 2017, Toronto, Ontario
The summit brought together experts across oncology to review present and future directions for oncology research and clinical care, describe the review and reimbursement pathway including challenges and barriers to access, and identify areas where patient advocates can collaborate to overcome some of the barriers to translate to increased access to innovative therapies and improved patient outcomes. Patient Advocates were invited to discuss and share opinions and thoughts about priority setting and tangible areas of improvement in the cancer care delivery and organization eco-system and the areas that, we as patient advocates can have an impact with a unified voice.
PRESENTATIONS
| Immunotheray for Cancer – Where are we now? | Dr. Marcus Butler, Medical Oncologist, Princess Margaret Cancer Centre |
| Oncolytic Viruses – Programmable Cancer Killing Machines |
Dr. John C. Bell, Senior Scientist, Centre for Innovative Cancer Research, Ottawa Hospital research Institute Professor, Department of Medicine and Biochemistry, Microbiology & Immunology, University of Ottawa |
| Precision Medicine – Today and Tomorrow | Monette Greenway, BSc., C. Dir. Principal and Co-Founder, Precision Rx-Dx Inc. |
| Building an Ideal World for Patient Outcomes in Oncology | Dr. Reiner Banken, Senior Fellow Institute for Clinical and Economic Review (ICER) |
| Barriers and Enablers for Innovative Medicine | Joanne Castonguay, Research Director, Institute for Research on Public Policy (IRPP) |
| Pulse Infoframe | Dr. Femida Gwadry‐Sridhar, Co‐Founder and CEO of Pulse Infoframe Inc. |
| Building an Ideal World for Patient Outcomes Myeloma | Martine M. Elias, B.Sc., M.Sc., Director Access, Advocacy and Community Relations Myeloma Canada |
| Panel Presentation | Marie Hotte, Scientific Coordinator, Drug Evaluation Directorate for Enrolment, Institut national d’excellence en santé et en services sociaux (INESSS) Imran Ali, Senior Manager, pan-Canadian Pharmaceutical Alliance Office (pCPA) Alex Chambers, Director, pan-Canadian Oncology Drug Review (pCODR) Scott Gavura, Director, Provincial Drug Reimbursement Programs Cancer Care Ontario (CCO) Heather Logan, Executive Director, Canadian Association of Provincial Cancer Agencies (CAPCA) |
| Key Note Speaker: Charting a Course: How HIV Paved the Way for Advocacy in Cancer |
Ryan Peck, Executive Director, HIV & AIDS Legal Clinic Ontario (HALCO) |